BMY
Bristol-Myers Squibb Co
Price:  
43.36 
USD
Volume:  
10,365,779.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy EV/EBITDA

153.8%
Upside

As of 2024-05-21, the EV/EBITDA ratio of Bristol-Myers Squibb Co (BMY) is 6.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bmy's latest enterprise value is 134,242.06 mil USD. Bmy's TTM EBITDA according to its financial statements is 20,217.00 mil USD. Dividing these 2 quantities gives us the above Bmy EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.7x - 21.7x 14.4x
Forward P/E multiples 20.7x - 26.2x 23.0x
Fair Price 53.93 - 193.16 110.03
Upside 24.4% - 345.5% 153.8%
43.36 USD
Stock Price
110.03 USD
Fair Price

Bmy EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-20 6.64
2024-05-17 6.71
2024-05-16 6.72
2024-05-15 6.76
2024-05-14 6.78
2024-05-13 6.81
2024-05-10 6.80
2024-05-09 6.78
2024-05-08 6.67
2024-05-07 6.71
2024-05-06 6.69
2024-05-03 6.70
2024-05-02 6.67
2024-05-01 6.73
2024-04-30 6.70
2024-04-29 6.77
2024-04-26 6.79
2024-04-25 6.77
2024-04-24 7.19
2024-04-23 7.20
2024-04-22 7.22
2024-04-19 7.20
2024-04-18 7.14
2024-04-17 7.09
2024-04-16 7.13
2024-04-15 7.16
2024-04-12 7.13
2024-04-11 7.22
2024-04-10 7.33
2024-04-09 7.47
2024-04-08 7.42
2024-04-05 7.44
2024-04-04 7.45
2024-04-03 7.52
2024-04-02 7.58
2024-04-01 7.61
2024-03-28 7.73
2024-03-27 7.63
2024-03-26 7.56
2024-03-25 7.53
2024-03-22 7.50
2024-03-21 7.47
2024-03-20 7.49
2024-03-19 7.49
2024-03-18 7.47
2024-03-15 7.54
2024-03-14 7.56
2024-03-13 7.57
2024-03-12 7.75
2024-03-11 7.74